Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Waverley Waves Goodbye To Generics As It Relinquishes ANDAs
Bortezomib And Pemetrexed ANDAs Transferred Back To Reliance Life Sciences
May 10 2024
•
By
Dave Wallace
Waverley is saying goodbye to its generics interests • Source: Shutterstock
More from Strategy
More from Business